￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Contraindications and precautions for taking Lynparza (Lipdrox) together with other drugs

2026-02-01 22:25:32

Check Details
Detailed explanation of venetoclax/venetoclax (venetoclax) onset time and treatment course evaluation recommendations

2026-02-01 22:25:32

Check Details
How long does it take for Asnib/Asiminib to take effect and evaluation of the course of treatment?

2026-02-01 22:25:32

Check Details
Regular purchasing channels for Ritlecitinib and precautions for patients when purchasing the drug

2026-02-01 22:25:32

Check Details
Treatment methods and coping strategies when side effects of sparsentan occur

2026-02-01 22:25:32

Check Details
Clinical trial data and efficacy analysis of ixazomib (Enleri)

2026-02-01 22:25:32

Check Details
Rubitidine/rubicatin (Zanbiga) contraindications and instructions for those who should use it with caution

2026-02-01 22:25:32

Check Details
Recommended medication time for Pimitespib and methods to improve efficacy

2026-02-01 22:25:32

Check Details
Comparison of the efficacy and side effects of afatinib (geterinib) and gefitinib

2026-02-01 22:25:32

Check Details
DaliRasheng (Keweike) drug interactions and precautions for combined use

2026-02-01 22:25:32

Check Details
Risks and treatment plans for discontinuation of Lynparza (Lipdrox) midway

2026-02-01 22:25:32

Check Details
Analysis of possible drug resistance mechanisms and countermeasures for venetoclax/venetoclax (Vekela)

2026-02-01 22:25:32

Check Details
Category
相关知识